Loading…
Genomic analysis for the prediction of prognosis in small-bowel cancer
The current understanding of clinicopathological features and genomic variants of small-bowel cancer is limited, in part due to the rarity of the disease. However, understanding of these factors is necessary for the development of novel therapeutic agents for small-bowel cancer. Thus, we aimed to id...
Saved in:
Published in: | PloS one 2021-05, Vol.16 (5), p.e0241454-e0241454 |
---|---|
Main Authors: | , , , , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c692t-c8b01478627218d71653adc7fc261b0394fef6841987abd6a5bcc83a09cc21103 |
---|---|
cites | cdi_FETCH-LOGICAL-c692t-c8b01478627218d71653adc7fc261b0394fef6841987abd6a5bcc83a09cc21103 |
container_end_page | e0241454 |
container_issue | 5 |
container_start_page | e0241454 |
container_title | PloS one |
container_volume | 16 |
creator | Tsuboi, Akiyoshi Urabe, Yuji Oka, Shiro Sumioka, Akihiko Iio, Sumio Yuge, Ryo Hayashi, Ryohei Kuwai, Toshio Kitadai, Yasuhiko Kuraoka, Kazuya Arihiro, Koji Tanaka, Shinji Chayama, Kazuaki |
description | The current understanding of clinicopathological features and genomic variants of small-bowel cancer is limited, in part due to the rarity of the disease. However, understanding of these factors is necessary for the development of novel therapeutic agents for small-bowel cancer. Thus, we aimed to identify the clinicopathological features and genomic variants associated with its prognosis and recurrence. We retrospectively examined 24 consecutive patients with primary small-bowel cancer surgically treated between May 2005 and August 2018 and collected 29 tumor specimens. The 29 lesions were subjected to mismatch repair status evaluation, using immunohistochemistry (IHC), and targeted genomic sequencing, after which they were analyzed using a panel of 90 cancer-related genes. IHC revealed that 45% (13/29) of the lesions exhibited deficient mismatch repair. The most common genomic variants in small-bowel cancers were in TP53 (48%, 13/27), followed by KRAS (44%, 12/27), ARID1A (33%, 9/27), PIK3CA (26%, 7/27), APC (26%, 7/27), and SMAD4, NOTCH3, CREBBP, PTCH1, and EP300 (22%, 6/27 each). Overall survival and disease-specific survival of patients with tumor mutational burden (TMB) ≥10 mutations/Mb (n = 17) were significantly better than those of patients with TMB |
doi_str_mv | 10.1371/journal.pone.0241454 |
format | article |
fullrecord | <record><control><sourceid>gale_plos_</sourceid><recordid>TN_cdi_plos_journals_2529910064</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A662418864</galeid><doaj_id>oai_doaj_org_article_381da59979794e2485ac0bd7b6effd09</doaj_id><sourcerecordid>A662418864</sourcerecordid><originalsourceid>FETCH-LOGICAL-c692t-c8b01478627218d71653adc7fc261b0394fef6841987abd6a5bcc83a09cc21103</originalsourceid><addsrcrecordid>eNqNkl1rFDEUhgdRbF39B6IDgujFrPmaTHIjlGLrQqHg123IZJLdLNlkTWbU_nsz3WnZkV5IIJ_PeU9y8hbFSwiWEDfwwzYM0Uu33AevlwARSGryqDiFHKOKIoAfH81PimcpbQGoMaP0aXGCCYCEN-C0uLjUPuysKmXWukk2lSbEst_och91Z1Vvgy-Dyauw9mE8t75MO-lc1Ybf2pVKeqXj8-KJkS7pF9O4KL5ffPp2_rm6ur5cnZ9dVYpy1FeKtTlxwyhqEGRdA2mNZacaoxCFLcCcGG0oI5CzRrYdlXWrFMMScKUQhAAvitcH3b0LSUwlSALViHMIACWZWB2ILsit2Ee7k_FGBGnF7UaIayFjb5XTAjPYyZrzJjeiEWG1VKDtmpZqYzrAs9bHKdvQ7nSntO-jdDPR-Ym3G7EOvwSDmNLcLYp3k0AMPwederGzSWnnpNdhGO-NIUKEYJTRN_-gD79uotYyP8B6E3JeNYqKM0qzCRi7pZYPULl1On919ouxeX8W8H4WkJle_-nXckhJrL5--X_2-secfXvEbrR0_SYFN4yuSnOQHEAVQ0pRm_siQyBGu99VQ4x2F5Pdc9ir4w-6D7rzN_4LHGf45w</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2529910064</pqid></control><display><type>article</type><title>Genomic analysis for the prediction of prognosis in small-bowel cancer</title><source>PMC (PubMed Central)</source><source>Publicly Available Content (ProQuest)</source><creator>Tsuboi, Akiyoshi ; Urabe, Yuji ; Oka, Shiro ; Sumioka, Akihiko ; Iio, Sumio ; Yuge, Ryo ; Hayashi, Ryohei ; Kuwai, Toshio ; Kitadai, Yasuhiko ; Kuraoka, Kazuya ; Arihiro, Koji ; Tanaka, Shinji ; Chayama, Kazuaki</creator><contributor>Shields, Anthony F.</contributor><creatorcontrib>Tsuboi, Akiyoshi ; Urabe, Yuji ; Oka, Shiro ; Sumioka, Akihiko ; Iio, Sumio ; Yuge, Ryo ; Hayashi, Ryohei ; Kuwai, Toshio ; Kitadai, Yasuhiko ; Kuraoka, Kazuya ; Arihiro, Koji ; Tanaka, Shinji ; Chayama, Kazuaki ; Shields, Anthony F.</creatorcontrib><description>The current understanding of clinicopathological features and genomic variants of small-bowel cancer is limited, in part due to the rarity of the disease. However, understanding of these factors is necessary for the development of novel therapeutic agents for small-bowel cancer. Thus, we aimed to identify the clinicopathological features and genomic variants associated with its prognosis and recurrence. We retrospectively examined 24 consecutive patients with primary small-bowel cancer surgically treated between May 2005 and August 2018 and collected 29 tumor specimens. The 29 lesions were subjected to mismatch repair status evaluation, using immunohistochemistry (IHC), and targeted genomic sequencing, after which they were analyzed using a panel of 90 cancer-related genes. IHC revealed that 45% (13/29) of the lesions exhibited deficient mismatch repair. The most common genomic variants in small-bowel cancers were in TP53 (48%, 13/27), followed by KRAS (44%, 12/27), ARID1A (33%, 9/27), PIK3CA (26%, 7/27), APC (26%, 7/27), and SMAD4, NOTCH3, CREBBP, PTCH1, and EP300 (22%, 6/27 each). Overall survival and disease-specific survival of patients with tumor mutational burden (TMB) ≥10 mutations/Mb (n = 17) were significantly better than those of patients with TMB <10 mutations/Mb (n = 6). Additionally, patients with a mutant SMAD4 had poorer recurrence-free survival than those with wild-type SMAD4. Our results suggested that TMB and SMAD4 mutations were associated with the prognosis of small-bowel cancer patients. Thus, cancer genomic analysis could be useful in the search for biomarkers of prognosis prediction in small-bowel cancers.</description><identifier>ISSN: 1932-6203</identifier><identifier>EISSN: 1932-6203</identifier><identifier>DOI: 10.1371/journal.pone.0241454</identifier><identifier>PMID: 34014970</identifier><language>eng</language><publisher>United States: Public Library of Science</publisher><subject>Analysis ; Antibodies ; Autoimmune diseases ; Biology and Life Sciences ; Body mass ; Body mass index ; Body size ; Cancer ; Celiac disease ; Classification ; Colorectal cancer ; Diagnosis ; Digestive tract ; Disease ; Editing ; Endoscopy ; Gastroenterology ; Gastrointestinal cancer ; Gastrointestinal tract ; Genetic aspects ; Genetic testing ; Genomic analysis ; Genomics ; Health aspects ; Health care facilities ; Hospitals ; Low fat diet ; Medical prognosis ; Medical records ; Medicine and Health Sciences ; Metabolism ; Metastasis ; Nutrient deficiency ; Obesity ; Pathology ; Patients ; Population ; Prognosis ; Race factors ; Regeneration ; Research facilities ; Small intestine ; Small intestine cancer ; Tumors</subject><ispartof>PloS one, 2021-05, Vol.16 (5), p.e0241454-e0241454</ispartof><rights>COPYRIGHT 2021 Public Library of Science</rights><rights>2021 Tsuboi et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2021 Tsuboi et al 2021 Tsuboi et al</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c692t-c8b01478627218d71653adc7fc261b0394fef6841987abd6a5bcc83a09cc21103</citedby><cites>FETCH-LOGICAL-c692t-c8b01478627218d71653adc7fc261b0394fef6841987abd6a5bcc83a09cc21103</cites><orcidid>0000-0003-0942-1541 ; 0000-0002-1652-0743</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2529910064/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2529910064?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,25753,27924,27925,37012,37013,44590,53791,53793,74998</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34014970$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><contributor>Shields, Anthony F.</contributor><creatorcontrib>Tsuboi, Akiyoshi</creatorcontrib><creatorcontrib>Urabe, Yuji</creatorcontrib><creatorcontrib>Oka, Shiro</creatorcontrib><creatorcontrib>Sumioka, Akihiko</creatorcontrib><creatorcontrib>Iio, Sumio</creatorcontrib><creatorcontrib>Yuge, Ryo</creatorcontrib><creatorcontrib>Hayashi, Ryohei</creatorcontrib><creatorcontrib>Kuwai, Toshio</creatorcontrib><creatorcontrib>Kitadai, Yasuhiko</creatorcontrib><creatorcontrib>Kuraoka, Kazuya</creatorcontrib><creatorcontrib>Arihiro, Koji</creatorcontrib><creatorcontrib>Tanaka, Shinji</creatorcontrib><creatorcontrib>Chayama, Kazuaki</creatorcontrib><title>Genomic analysis for the prediction of prognosis in small-bowel cancer</title><title>PloS one</title><addtitle>PLoS One</addtitle><description>The current understanding of clinicopathological features and genomic variants of small-bowel cancer is limited, in part due to the rarity of the disease. However, understanding of these factors is necessary for the development of novel therapeutic agents for small-bowel cancer. Thus, we aimed to identify the clinicopathological features and genomic variants associated with its prognosis and recurrence. We retrospectively examined 24 consecutive patients with primary small-bowel cancer surgically treated between May 2005 and August 2018 and collected 29 tumor specimens. The 29 lesions were subjected to mismatch repair status evaluation, using immunohistochemistry (IHC), and targeted genomic sequencing, after which they were analyzed using a panel of 90 cancer-related genes. IHC revealed that 45% (13/29) of the lesions exhibited deficient mismatch repair. The most common genomic variants in small-bowel cancers were in TP53 (48%, 13/27), followed by KRAS (44%, 12/27), ARID1A (33%, 9/27), PIK3CA (26%, 7/27), APC (26%, 7/27), and SMAD4, NOTCH3, CREBBP, PTCH1, and EP300 (22%, 6/27 each). Overall survival and disease-specific survival of patients with tumor mutational burden (TMB) ≥10 mutations/Mb (n = 17) were significantly better than those of patients with TMB <10 mutations/Mb (n = 6). Additionally, patients with a mutant SMAD4 had poorer recurrence-free survival than those with wild-type SMAD4. Our results suggested that TMB and SMAD4 mutations were associated with the prognosis of small-bowel cancer patients. Thus, cancer genomic analysis could be useful in the search for biomarkers of prognosis prediction in small-bowel cancers.</description><subject>Analysis</subject><subject>Antibodies</subject><subject>Autoimmune diseases</subject><subject>Biology and Life Sciences</subject><subject>Body mass</subject><subject>Body mass index</subject><subject>Body size</subject><subject>Cancer</subject><subject>Celiac disease</subject><subject>Classification</subject><subject>Colorectal cancer</subject><subject>Diagnosis</subject><subject>Digestive tract</subject><subject>Disease</subject><subject>Editing</subject><subject>Endoscopy</subject><subject>Gastroenterology</subject><subject>Gastrointestinal cancer</subject><subject>Gastrointestinal tract</subject><subject>Genetic aspects</subject><subject>Genetic testing</subject><subject>Genomic analysis</subject><subject>Genomics</subject><subject>Health aspects</subject><subject>Health care facilities</subject><subject>Hospitals</subject><subject>Low fat diet</subject><subject>Medical prognosis</subject><subject>Medical records</subject><subject>Medicine and Health Sciences</subject><subject>Metabolism</subject><subject>Metastasis</subject><subject>Nutrient deficiency</subject><subject>Obesity</subject><subject>Pathology</subject><subject>Patients</subject><subject>Population</subject><subject>Prognosis</subject><subject>Race factors</subject><subject>Regeneration</subject><subject>Research facilities</subject><subject>Small intestine</subject><subject>Small intestine cancer</subject><subject>Tumors</subject><issn>1932-6203</issn><issn>1932-6203</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNqNkl1rFDEUhgdRbF39B6IDgujFrPmaTHIjlGLrQqHg123IZJLdLNlkTWbU_nsz3WnZkV5IIJ_PeU9y8hbFSwiWEDfwwzYM0Uu33AevlwARSGryqDiFHKOKIoAfH81PimcpbQGoMaP0aXGCCYCEN-C0uLjUPuysKmXWukk2lSbEst_och91Z1Vvgy-Dyauw9mE8t75MO-lc1Ybf2pVKeqXj8-KJkS7pF9O4KL5ffPp2_rm6ur5cnZ9dVYpy1FeKtTlxwyhqEGRdA2mNZacaoxCFLcCcGG0oI5CzRrYdlXWrFMMScKUQhAAvitcH3b0LSUwlSALViHMIACWZWB2ILsit2Ee7k_FGBGnF7UaIayFjb5XTAjPYyZrzJjeiEWG1VKDtmpZqYzrAs9bHKdvQ7nSntO-jdDPR-Ym3G7EOvwSDmNLcLYp3k0AMPwederGzSWnnpNdhGO-NIUKEYJTRN_-gD79uotYyP8B6E3JeNYqKM0qzCRi7pZYPULl1On919ouxeX8W8H4WkJle_-nXckhJrL5--X_2-secfXvEbrR0_SYFN4yuSnOQHEAVQ0pRm_siQyBGu99VQ4x2F5Pdc9ir4w-6D7rzN_4LHGf45w</recordid><startdate>20210520</startdate><enddate>20210520</enddate><creator>Tsuboi, Akiyoshi</creator><creator>Urabe, Yuji</creator><creator>Oka, Shiro</creator><creator>Sumioka, Akihiko</creator><creator>Iio, Sumio</creator><creator>Yuge, Ryo</creator><creator>Hayashi, Ryohei</creator><creator>Kuwai, Toshio</creator><creator>Kitadai, Yasuhiko</creator><creator>Kuraoka, Kazuya</creator><creator>Arihiro, Koji</creator><creator>Tanaka, Shinji</creator><creator>Chayama, Kazuaki</creator><general>Public Library of Science</general><general>Public Library of Science (PLoS)</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>IOV</scope><scope>ISR</scope><scope>3V.</scope><scope>7QG</scope><scope>7QL</scope><scope>7QO</scope><scope>7RV</scope><scope>7SN</scope><scope>7SS</scope><scope>7T5</scope><scope>7TG</scope><scope>7TM</scope><scope>7U9</scope><scope>7X2</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FD</scope><scope>8FE</scope><scope>8FG</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABJCF</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>ARAPS</scope><scope>ATCPS</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BGLVJ</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>D1I</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>KB.</scope><scope>KB0</scope><scope>KL.</scope><scope>L6V</scope><scope>LK8</scope><scope>M0K</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>M7P</scope><scope>M7S</scope><scope>NAPCQ</scope><scope>P5Z</scope><scope>P62</scope><scope>P64</scope><scope>PATMY</scope><scope>PDBOC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PTHSS</scope><scope>PYCSY</scope><scope>RC3</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0003-0942-1541</orcidid><orcidid>https://orcid.org/0000-0002-1652-0743</orcidid></search><sort><creationdate>20210520</creationdate><title>Genomic analysis for the prediction of prognosis in small-bowel cancer</title><author>Tsuboi, Akiyoshi ; Urabe, Yuji ; Oka, Shiro ; Sumioka, Akihiko ; Iio, Sumio ; Yuge, Ryo ; Hayashi, Ryohei ; Kuwai, Toshio ; Kitadai, Yasuhiko ; Kuraoka, Kazuya ; Arihiro, Koji ; Tanaka, Shinji ; Chayama, Kazuaki</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c692t-c8b01478627218d71653adc7fc261b0394fef6841987abd6a5bcc83a09cc21103</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Analysis</topic><topic>Antibodies</topic><topic>Autoimmune diseases</topic><topic>Biology and Life Sciences</topic><topic>Body mass</topic><topic>Body mass index</topic><topic>Body size</topic><topic>Cancer</topic><topic>Celiac disease</topic><topic>Classification</topic><topic>Colorectal cancer</topic><topic>Diagnosis</topic><topic>Digestive tract</topic><topic>Disease</topic><topic>Editing</topic><topic>Endoscopy</topic><topic>Gastroenterology</topic><topic>Gastrointestinal cancer</topic><topic>Gastrointestinal tract</topic><topic>Genetic aspects</topic><topic>Genetic testing</topic><topic>Genomic analysis</topic><topic>Genomics</topic><topic>Health aspects</topic><topic>Health care facilities</topic><topic>Hospitals</topic><topic>Low fat diet</topic><topic>Medical prognosis</topic><topic>Medical records</topic><topic>Medicine and Health Sciences</topic><topic>Metabolism</topic><topic>Metastasis</topic><topic>Nutrient deficiency</topic><topic>Obesity</topic><topic>Pathology</topic><topic>Patients</topic><topic>Population</topic><topic>Prognosis</topic><topic>Race factors</topic><topic>Regeneration</topic><topic>Research facilities</topic><topic>Small intestine</topic><topic>Small intestine cancer</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Tsuboi, Akiyoshi</creatorcontrib><creatorcontrib>Urabe, Yuji</creatorcontrib><creatorcontrib>Oka, Shiro</creatorcontrib><creatorcontrib>Sumioka, Akihiko</creatorcontrib><creatorcontrib>Iio, Sumio</creatorcontrib><creatorcontrib>Yuge, Ryo</creatorcontrib><creatorcontrib>Hayashi, Ryohei</creatorcontrib><creatorcontrib>Kuwai, Toshio</creatorcontrib><creatorcontrib>Kitadai, Yasuhiko</creatorcontrib><creatorcontrib>Kuraoka, Kazuya</creatorcontrib><creatorcontrib>Arihiro, Koji</creatorcontrib><creatorcontrib>Tanaka, Shinji</creatorcontrib><creatorcontrib>Chayama, Kazuaki</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>Opposing Viewpoints in Context (Gale)</collection><collection>Science (Gale in Context)</collection><collection>ProQuest Central (Corporate)</collection><collection>Animal Behavior Abstracts</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Biotechnology Research Abstracts</collection><collection>Nursing & Allied Health Database (ProQuest)</collection><collection>Ecology Abstracts</collection><collection>Entomology Abstracts (Full archive)</collection><collection>Immunology Abstracts</collection><collection>Meteorological & Geoastrophysical Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Agricultural Science Collection</collection><collection>Health & Medical Collection (Proquest)</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database (Proquest)</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Technology Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Materials Science & Engineering Collection</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central</collection><collection>Advanced Technologies & Aerospace Collection</collection><collection>Agricultural & Environmental Science Collection</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Technology Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Materials Science Collection</collection><collection>ProQuest Central</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection (Proquest) (PQ_SDU_P3)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>ProQuest Materials Science Database</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Meteorological & Geoastrophysical Abstracts - Academic</collection><collection>ProQuest Engineering Collection</collection><collection>Biological Sciences</collection><collection>Agriculture Science Database</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>ProQuest Engineering Database</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest Advanced Technologies & Aerospace Database</collection><collection>ProQuest Advanced Technologies & Aerospace Collection</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Environmental Science Database</collection><collection>Materials Science Collection</collection><collection>Publicly Available Content (ProQuest)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>Engineering Collection</collection><collection>Environmental Science Collection</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>PloS one</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Tsuboi, Akiyoshi</au><au>Urabe, Yuji</au><au>Oka, Shiro</au><au>Sumioka, Akihiko</au><au>Iio, Sumio</au><au>Yuge, Ryo</au><au>Hayashi, Ryohei</au><au>Kuwai, Toshio</au><au>Kitadai, Yasuhiko</au><au>Kuraoka, Kazuya</au><au>Arihiro, Koji</au><au>Tanaka, Shinji</au><au>Chayama, Kazuaki</au><au>Shields, Anthony F.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Genomic analysis for the prediction of prognosis in small-bowel cancer</atitle><jtitle>PloS one</jtitle><addtitle>PLoS One</addtitle><date>2021-05-20</date><risdate>2021</risdate><volume>16</volume><issue>5</issue><spage>e0241454</spage><epage>e0241454</epage><pages>e0241454-e0241454</pages><issn>1932-6203</issn><eissn>1932-6203</eissn><abstract>The current understanding of clinicopathological features and genomic variants of small-bowel cancer is limited, in part due to the rarity of the disease. However, understanding of these factors is necessary for the development of novel therapeutic agents for small-bowel cancer. Thus, we aimed to identify the clinicopathological features and genomic variants associated with its prognosis and recurrence. We retrospectively examined 24 consecutive patients with primary small-bowel cancer surgically treated between May 2005 and August 2018 and collected 29 tumor specimens. The 29 lesions were subjected to mismatch repair status evaluation, using immunohistochemistry (IHC), and targeted genomic sequencing, after which they were analyzed using a panel of 90 cancer-related genes. IHC revealed that 45% (13/29) of the lesions exhibited deficient mismatch repair. The most common genomic variants in small-bowel cancers were in TP53 (48%, 13/27), followed by KRAS (44%, 12/27), ARID1A (33%, 9/27), PIK3CA (26%, 7/27), APC (26%, 7/27), and SMAD4, NOTCH3, CREBBP, PTCH1, and EP300 (22%, 6/27 each). Overall survival and disease-specific survival of patients with tumor mutational burden (TMB) ≥10 mutations/Mb (n = 17) were significantly better than those of patients with TMB <10 mutations/Mb (n = 6). Additionally, patients with a mutant SMAD4 had poorer recurrence-free survival than those with wild-type SMAD4. Our results suggested that TMB and SMAD4 mutations were associated with the prognosis of small-bowel cancer patients. Thus, cancer genomic analysis could be useful in the search for biomarkers of prognosis prediction in small-bowel cancers.</abstract><cop>United States</cop><pub>Public Library of Science</pub><pmid>34014970</pmid><doi>10.1371/journal.pone.0241454</doi><tpages>e0241454</tpages><orcidid>https://orcid.org/0000-0003-0942-1541</orcidid><orcidid>https://orcid.org/0000-0002-1652-0743</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1932-6203 |
ispartof | PloS one, 2021-05, Vol.16 (5), p.e0241454-e0241454 |
issn | 1932-6203 1932-6203 |
language | eng |
recordid | cdi_plos_journals_2529910064 |
source | PMC (PubMed Central); Publicly Available Content (ProQuest) |
subjects | Analysis Antibodies Autoimmune diseases Biology and Life Sciences Body mass Body mass index Body size Cancer Celiac disease Classification Colorectal cancer Diagnosis Digestive tract Disease Editing Endoscopy Gastroenterology Gastrointestinal cancer Gastrointestinal tract Genetic aspects Genetic testing Genomic analysis Genomics Health aspects Health care facilities Hospitals Low fat diet Medical prognosis Medical records Medicine and Health Sciences Metabolism Metastasis Nutrient deficiency Obesity Pathology Patients Population Prognosis Race factors Regeneration Research facilities Small intestine Small intestine cancer Tumors |
title | Genomic analysis for the prediction of prognosis in small-bowel cancer |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T16%3A50%3A52IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_plos_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Genomic%20analysis%20for%20the%20prediction%20of%20prognosis%20in%20small-bowel%20cancer&rft.jtitle=PloS%20one&rft.au=Tsuboi,%20Akiyoshi&rft.date=2021-05-20&rft.volume=16&rft.issue=5&rft.spage=e0241454&rft.epage=e0241454&rft.pages=e0241454-e0241454&rft.issn=1932-6203&rft.eissn=1932-6203&rft_id=info:doi/10.1371/journal.pone.0241454&rft_dat=%3Cgale_plos_%3EA662418864%3C/gale_plos_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c692t-c8b01478627218d71653adc7fc261b0394fef6841987abd6a5bcc83a09cc21103%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2529910064&rft_id=info:pmid/34014970&rft_galeid=A662418864&rfr_iscdi=true |